TR201000727A2 - Formoterol ve mometazon içeren farmasötik bileşimler. - Google Patents

Formoterol ve mometazon içeren farmasötik bileşimler.

Info

Publication number
TR201000727A2
TR201000727A2 TR2010/00727A TR201000727A TR201000727A2 TR 201000727 A2 TR201000727 A2 TR 201000727A2 TR 2010/00727 A TR2010/00727 A TR 2010/00727A TR 201000727 A TR201000727 A TR 201000727A TR 201000727 A2 TR201000727 A2 TR 201000727A2
Authority
TR
Turkey
Prior art keywords
mometasone
formoterol
pharmaceutical compositions
compositions
polymorphs
Prior art date
Application number
TR2010/00727A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/00727A priority Critical patent/TR201000727A2/tr
Priority to EP11706962A priority patent/EP2533765A2/en
Priority to PCT/TR2011/000017 priority patent/WO2011093815A2/en
Publication of TR201000727A2 publication Critical patent/TR201000727A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş solunum yolu rahatsızlıklarının tedavisinde kullanılmak üzere inhalasyon yolu ile uygulanan formoterol ile mometazon ve/veya bunların farmasötik olarak kabul edilebilir hidratları, solvatları, esterleri, enantiomerleri, polimorfları, tuzları, kristal ve/veya amorf formunu veya serbest baz formunu ve/veya bunların kombinasyonunu içeren kuru toz formundaki farmasötik bileşimler ve bu bileşimlerin spesifik bir iletim yöntemine yöneliktir.
TR2010/00727A 2010-01-29 2010-02-02 Formoterol ve mometazon içeren farmasötik bileşimler. TR201000727A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/00727A TR201000727A2 (tr) 2010-02-02 2010-02-02 Formoterol ve mometazon içeren farmasötik bileşimler.
EP11706962A EP2533765A2 (en) 2010-01-29 2011-01-28 Pharmaceutical compositions comprising formoterol and mometasone
PCT/TR2011/000017 WO2011093815A2 (en) 2010-01-29 2011-01-28 Pharmaceutical compositions comprising formoterol and mometasone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00727A TR201000727A2 (tr) 2010-02-02 2010-02-02 Formoterol ve mometazon içeren farmasötik bileşimler.

Publications (1)

Publication Number Publication Date
TR201000727A2 true TR201000727A2 (tr) 2011-08-22

Family

ID=44168913

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00727A TR201000727A2 (tr) 2010-01-29 2010-02-02 Formoterol ve mometazon içeren farmasötik bileşimler.

Country Status (1)

Country Link
TR (1) TR201000727A2 (tr)

Similar Documents

Publication Publication Date Title
CY1121150T1 (el) Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας
CY1118839T1 (el) Επικαλυμμενη φαρμακευτικη συνθεση που περιεχει ρεγοραφενιμπη
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
UA108640C2 (uk) Похідні n-(імідазопіримідин-7-іл)гетероариламідів та їх застосування як інгібіторів pde10a
MX2015007531A (es) Composiciones de gamma-hidroxibutirato y sus usos para el tratamiento de trastornos.
CL2012003428A1 (es) Compuestos derivados de 5,6-dihidro-2h-(1,4)oxazin-3-il amina, inhibidores bace; composición farmacéutica que los comprende; proceso de preparación de la composición; y su uso en el tratamiento del alzheimer, demencia, síndrome de down, entre otras.
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
UA110943C2 (uk) N-ацилсульфонамідні промотори апоптозу
MX2016002794A (es) Compuestos antiproliferativos.
IN2014DN10670A (tr)
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου
GB201209587D0 (en) Therapeutic compounds
MX2013011931A (es) Compuestos de cromenona como inhibidores de pi 3-quinasa para el tratamiento del cancer.
EA029499B9 (ru) Ингибиторы rorc2 и способы их применения
TW201613864A (en) Novel compounds
CY1120098T1 (el) Συνθεσεις που περιεχουν βορτιοξετινη και δονεπεζιλη
AR079945A1 (es) Derivados de pirazina como inhibidores de glucogeno sintasa quinasa 3 (gsk3)
CY1120133T1 (el) Πυριδαζινονες ως αναστολεις ενζυμου daao
MX2016002302A (es) Composiciones y metodos terapeuticos para la regresion acelerada de placa.
MX2016004934A (es) Derivados de aminotetralina y aminoindano, composiciones farmaceuticas que los contienen, y su uso en terapia.
EA201491227A1 (ru) Новые производные морфолинила, подходящие для применения в качестве ингибиторов mogat-2
TR201000685A2 (tr) Salmeterol ve flutikazon içeren farmasötik preparatlar.
TR201819805T4 (tr) Flavaglin türevleri̇.
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
TR201000689A1 (tr) Sefprozil içeren katı dozaj formlar.